Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / GENOMICS IMMUN
-
Total 13F shares
-
1,114,144
-
Share change
-
+112,042
-
Total reported value
-
$47,204,226
-
Price per share
-
$38.96
-
Number of holders
-
47
-
Value change
-
+$4,596,058
-
Number of buys
-
32
-
Number of sells
-
13
Institutional Holders of ISHARES TR - GENOMICS IMMUN (IDNA) as of Q3 2020
As of 30 Sep 2020,
ISHARES TR - GENOMICS IMMUN (IDNA) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,114,144 shares.
The largest 10 holders included
Thrivent Financial for Lutherans, RETIREMENT CAPITAL STRATEGIES, UBS Group AG, ROYAL BANK OF CANADA, STRATEGIC WEALTH MANAGEMENT INC, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., STIFEL FINANCIAL CORP, LPL Financial LLC, Sandell Asset Management Corp., and BANK OF AMERICA CORP /DE/.
This page lists
47
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.